Zoetis Inc. (ZTS) Stock

Zoetis Inc. is a prominent leader in the field of animal health, specializing in the discovery, development, manufacturing, and commercialization of medicines, vaccines, and diagnostic products worldwide. With a focus on both livestock and companion animals, Zoetis serves a broad spectrum of species including cattle, swine, poultry, fish, sheep, dogs, cats, and horses. The company's comprehensive portfolio includes vaccines designed to prevent diseases affecting respiratory, gastrointestinal, and reproductive systems, alongside anti-infectives that combat bacterial, fungal, and protozoal infections, and parasiticides that target external and internal parasites such as fleas, ticks, and worms.

In addition to its pharmaceutical offerings, Zoetis provides a range of other products including pain management, sedation, reproductive health, oncology treatments, dermatology solutions for allergic conditions, and medicated feed additives for livestock. The company also excels in diagnostic solutions, offering portable blood and urine analysis testing, point-of-care diagnostic products, rapid immunoassay tests, reference laboratory kits, blood glucose monitors, and other critical veterinary diagnostics. Furthermore, Zoetis engages in non-pharmaceutical areas such as nutritionals, agribusiness services, biodevices, genetics tests, and precision animal health solutions.

Founded in 1952 and headquartered in Parsippany, New Jersey, Zoetis markets its products globally to veterinarians, livestock producers, retail outlets, and third-party veterinary distributors. Leveraging a dedicated team of sales representatives, technical specialists, and veterinary operations experts, Zoetis is committed to advancing animal health by delivering innovative solutions that improve the well-being and productivity of animals across diverse environments and species.